|
Volumn 13, Issue 2, 2012, Pages 157-159
|
Successful long-term treatment with pemetrexed of NSCLC associated with EML4-ALK and low thymidylate synthase expression
|
Author keywords
EML4 ALK; NSCLC; Pemetrexed; Predictive marker; Thymidylate synthase
|
Indexed keywords
ANAPLASTIC LYMPHOMA KINASE;
CARBOPLATIN;
ECHINODERM MICROTUBULE ASSOCIATED PROTEIN LIKE 4;
EPIDERMAL GROWTH FACTOR RECEPTOR;
MEMBRANE PROTEIN;
PEMETREXED;
THYMIDYLATE SYNTHASE;
UNCLASSIFIED DRUG;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
CANCER CHEMOTHERAPY;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
FEMALE;
FLUORESCENCE IN SITU HYBRIDIZATION;
FUSION GENE;
GENETIC VARIABILITY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LONG TERM CARE;
LUNG NON SMALL CELL CANCER;
MUTATIONAL ANALYSIS;
PREDICTIVE VALUE;
PROTEIN EXPRESSION;
REAL TIME POLYMERASE CHAIN REACTION;
THORAX RADIOGRAPHY;
TREATMENT DURATION;
TREATMENT RESPONSE;
ADENOCARCINOMA;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SIGNET RING CELL;
FEMALE;
GLUTAMATES;
GUANINE;
HUMANS;
IMMUNOENZYME TECHNIQUES;
LUNG NEOPLASMS;
MIDDLE AGED;
ONCOGENE PROTEINS, FUSION;
PLEURAL NEOPLASMS;
PROGNOSIS;
THYMIDYLATE SYNTHASE;
TIME FACTORS;
|
EID: 84863150140
PISSN: 15257304
EISSN: 19380690
Source Type: Journal
DOI: 10.1016/j.cllc.2011.09.003 Document Type: Article |
Times cited : (8)
|
References (5)
|